Pasar al contenido principal

REPROGRAMACION METABOLICA Y REDOX DE NEURONAS IN VIVO COMO ESTRATEGIA TERAPEUTICA FRENTE A ENFERMEDADES NEUROLOGICAS

SAF2016-78114-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SALAMANCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 22
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Hippocampal neurons require a large pool of glutathione to sustain dendrite integrity and cognitive function

  • Fernandez-Fernandez, Seila
  • Bobo-Jimenez, Veronica
  • Requejo-Aguilar, Raquel
  • Gonzalez-Fernandez, Silvia
  • Resch, Monica
  • Carabias-Carrascoa, Monica
  • Ros Salvador, Joaquim
  • Almeida, Angeles
  • Bolaños, Juan P.
Loss of brain glutathione has been associated with cognitive decline and neuronal death during aging and neurodegenerative diseases. However, whether decreased glutathione precedes or follows neuronal dysfunction has not been unambiguously elucidated. Previous attempts to address this issue were approached by fully eliminating glutathione, a strategy causing abrupt lethality or premature neuronal death that led to multiple interpretations. To overcome this drawback, here we aimed to moderately decrease glutathione content by genetically knocking down the rate-limiting enzyme of glutathione biosynthesis in mouse neurons in vivo. Biochemical and morphological analyses of the brain revealed a modest glutathione decrease and redox stress throughout the hippocampus, although neuronal dendrite disruption and glial activation was confined to the hippocampal CA1 layer. Furthermore, the behavioral characterization exhibited signs consistent with cognitive impairment. These results indicate that the hippocampal neurons require a large pool of glutathione to sustain dendrite integrity and cognitive function., This work was funded by the MINECO, Spain (SAF2016-78114-R to JPB; Red de Excelencia CONSOLREDOX SAF2015-71521-REDC to JPB and JR), H2020 European Commission, Belgium (BatCure Grant 666918 to JPB; PANA grant 686009 to AA), Instituto de Salud Carlos III, Spain (CIBERFES CB16/10/00282 to JPB; PI15/00473 and RD16/ 0019/0018 to AA), Junta de Castilla y León, Spain (IES007P17) and Fundación Ramón Areces, Spain (to AA). This work was funded by FEDER, European Commission, Belgium.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

APC/CCdh1-Rock2 pathway controls dendritic integrity and memory

  • Bobo-Jimenez, Veronica
  • Delgado-Esteban, María
  • Angibaud, Julie
  • Sánchez Morán, Irene
  • Fuente, Antonio de la
  • Yajeya, Javier
  • Nägerl, U. Valentin
  • Castillo, José
  • Bolaños, Juan P.
  • Almeida, Angeles
Disruption of neuronal morphology contributes to the pathology of neurodegenerative disorders such as Alzheimer's disease (AD). However, the underlying molecular mechanisms are unknown. Here, we show that postnatal deletion of Cdh1, a cofactor of the anaphasepromoting complex/cyclosome (APC/C) ubiquitin ligase in neurons [Cdh1 conditional knockout (cKO)], disrupts dendrite arborization and causes dendritic spine and synapse loss in the cortex and hippocampus, concomitant with memory impairment and neurodegeneration, in adult mice. We found that the dendrite destabilizer Rho protein kinase 2 (Rock2), which accumulates in the brain of AD patients, is an APC/C substrate in vivo and that Rock2 protein and activity increased in the cortex and hippocampus of Cdh1 cKO mice. In these animals, inhibition of Rock activity, using the clinically approved drug fasudil, prevented dendritic network disorganization, memory loss, and neurodegeneration. Thus, APC/C-mediated degradation of Rock2 maintains the dendritic network, memory formation, and neuronal survival, suggesting that pharmacological inhibition of aberrantly accumulated Rock2 may be a suitable therapeutic strategy against neurodegeneration., This work was funded by Instituto de Salud Carlos III Grants PI15/00473, BAE14/0005, RD12/0014/0007, and RD16/0019/0018 (to A.A.) and RD12/0014/0001 and RD16/0019/0001 (to J.C.); FEDER (European Regional Development Fund); Ministerio de Economía y Competitividad Grant SAF2016-78114-R (to J.P.B.); and European Union’s Horizon 2020 Research and Innovation Programme Grant 686009 (to A.A. and J.C.). V.B.-J. (PI15/00473) and M.D.-E. (CP0014/00010) are supported by the Instituto de Salud Carlos III. I.S.-M. is supported by the Junta de Castilla y León (Spain)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Current technical approaches to brain energy metabolism

  • Barros, L. Felipe
  • Bolaños, Juan P.
  • Bonvento, Gilles
  • Bouzier-Sore, Anne-Karine
  • Brown, Angus
  • Hirrlinger, Johannes
  • Kasparov, Sergey
  • Kirchhoff, Frank
  • Murphy, Anne N.
  • Pellerin, Luc
  • Robinson, Michael B.
  • Weber, Bruno
Neuroscience is a technology‐driven discipline and brain energy metabolism is no exception. Once satisfied with mapping metabolic pathways at organ level, we are now looking to learn what it is exactly that metabolic enzymes and transporters do and when, where do they reside, how are they regulated, and how do they relate to the specific functions of neurons, glial cells, and their subcellular domains and organelles, in different areas of the brain. Moreover, we aim to quantify the fluxes of metabolites within and between cells. Energy metabolism is not just a necessity for proper cell function and viability but plays specific roles in higher brain functions such as memory processing and behavior, whose mechanisms need to be understood at all hierarchical levels, from isolated proteins to whole subjects, in both health and disease. To this aim, the field takes advantage of diverse disciplines including anatomy, histology, physiology, biochemistry, bioenergetics, cellular biology, molecular biology, developmental biology, neurology, and mathematical modeling. This article presents a well‐referenced synopsis of the technical side of brain energy metabolism research. Detail and jargon are avoided whenever possible and emphasis is given to comparative strengths, limitations, and weaknesses, information that is often not available in regular articles., Fondecyt, Grant Number: 1160317; MINECO, Grant Numbers: SAF2016‐78114‐R and RTC‐2015‐3237‐1; CIBERFES, Grant Numer: CB16/10/00282; SP3‐People‐MC‐ITN program, Grant Number: 608381; EU BATCure, Grant Number: 666918; FEDER (European regional development fund); Investissement d'Avenir, Grant Number: ANR‐11‐INBS‐0011; French State in the context of the “Investments for the future” Program IdEx and the LabEx TRAIL, Grant Numbers: ANR‐10‐IDEX and ANR‐10‐LABX‐57; French–Swiss ANR‐FNS, Grant Numer: ANR‐15‐ CE37‐0012. University of Nottingham; BBSRC, Grant Numers: BB/L019396/1 and BB/K009192/1; MRC, Grant Number: MR/L020661/1; Deutsche Forschungsgemeinschaft, Grant Numers: DFG SPP 1757, SFB 894, and FOR 2289; European Commission, Grant Number: H2020‐FETPROACT 732344; Neurofibres, Grant Number: H2020‐MSCA‐ITN‐722053 EU‐GliaPhD; US National Institutes of Health, Grant Number: R01NS087611; Teva Pharmaceuticals; Agilent Technologies. IdEx, Grant Number: ANR‐10‐IDEX‐03‐02; French–Swiss ANR‐FNS, Grant number: 310030E‐164271; National Institutes of Neurologic Disease and Stroke at the National Institutes of Health, Grant Numer: R01 NS077773; University of Zurich and the Swiss National Science Foundation; Comisión Nacional de Investigación Científica y Tecnológica, Grant Numer: PB 01; Fondo Nacional de Desarrollo Científico y Tecnológico, Grant Numer: 1160317; Ministerio de Economía y Competitividad, Grant Numer: RTC‐2015‐3237‐1,SAF2016‐78114‐R; Agence Nationale de la Recherche, Grant Numers: ANR‐10‐IDEX, ANR‐10‐IDEX‐03‐02, ANR‐10‐LABX‐57, ANR‐11‐INBS‐0011, and ANR‐15‐ CE37‐0012; Biotechnology and Biological Sciences Research Council, Grant Numers: BB/L019396/1 and BB/K009192/1; Medical Research Council, Grant Numer: MR/L020661/1., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mitochondrial Complex I Activity is Conditioned by Supercomplex I–III2–IV Assembly in Brain Cells: Relevance for Parkinson’s Disease

  • López-Fabuel, Irene
  • Resch-Beusher, Monica
  • Carabias-Carrasco, Mónica
  • Almeida, Angeles
  • Bolaños, Juan P.
The assembly of complex I (CI) with complexes III (CIII) and IV (CIV) of the mitochondrial respiratory chain (MRC) to configure I–III- or I–III–IV-containing supercomplexes (SCs) regulates mitochondrial energy efficiency and reactive oxygen species (mROS) production. However, whether the occurrence of SCs impacts on CI specific activity remains unknown to our knowledge. To investigate this issue, here we determined CI activity in primary neurons and astrocytes, cultured under identical antioxidants-free medium, from two mouse strains (C57Bl/6 and CBA) and Wistar rat, i.e. three rodent species with or without the ability to assemble CIV into SCs. We found that CI activity was 6- or 1.8-fold higher in astrocytes than in neurons, respectively, from rat or CBA mouse, which can form I–III2–IV SC; however, CI activity was similar in the cells from C57Bl/6 mouse, which does not form I–III2–IV SC. Interestingly, CII–III activity, which was comparable in neurons and astrocytes from mice, was about 50% lower in astrocytes when compared with neurons from rat, a difference that was abolished by antioxidants- or serum-containing media. CIV and citrate synthase activities were similar under all conditions studied. Interestingly, in rat astrocytes, CI abundance in I–III2–IV SC was negligible when compared with its abundance in I–III-containing SCs. Thus, CIV-containing SCs formation may determine CI specific activity in astrocytes, which is important to understand the mechanism for CI deficiency observed in Parkinson’s disease., J.P.B. is funded by MINECO (SAF2013-41177-R, SAF2016-78114-R), CIBER on Frailty and Aging from the Instituto de Salud Carlos III (CB16/10/00282), E.U. SP3-People-MC-ITN programme (608381), EU BATCure Grant (666918) and FEDER (European regional development fund). A.A.P. is funded by the Instituto de Salud Carlos III (RD12/0014/0007)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mitochondrial respiratory chain disorganization in Parkinson's disease-relevant PINK1 and DJ1 mutants

  • López-Fabuel, Irene
  • Martín-Martín, Lucía
  • Resch-Beusher, Monica
  • Azkona, Garikoitz
  • Sánchez-Pernaute, Rosario
  • Bolaños, Juan P.
Brain mitochondrial complex I (CI) damage is associated with the loss of the dopaminergic neurons of the Substantia Nigra in Parkinson's Disease (PD) patients. However, whether CI inhibition is associated with any alteration of the mitochondrial respiratory chain (MRC) organization in PD patients is unknown. To address this issue, here we analyzed the MRC by blue native gel electrophoresis (BNGE) followed by western blotting, in mitochondria purified from fibroblasts of patients harboring PD-relevant Pink1 mutations. We found a decrease in free CI, and in free versus supercomplexes (SCs)-assembled CI in PD; however, free complex III (CIII) was only modestly affected, whereas its free versus SCs-assembled forms decreased. Interestingly, complex IV (CIV) was considerably lost in the PD samples. These results were largely confirmed in mitochondria isolated from cultured neurons from Pink1-/- mice, and in cultured neurons and forebrain samples from the PD-related Dj1-/- mice. Thus, besides CI damage, the MRC undergoes a profound structural remodeling in PD likely responsible for the energetic inefficiency and mitochondrial reactive oxygen species (mROS) over-production observed in this disease., J.P.B. is funded by MINECO (SAF2016-78114-R; RTC-2015-3237-1), CIBERFES (CB16/10/00282), E.U. SP3-People-MC-ITN programme (608381), EU BATCure grant (666918) and FEDER (European regional development fund). R.S.P. is funded by the Joint Program in Neurodegenerative Diseases (DAMNDPATHS)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization

  • Lapresa, Rebeca
  • Agulla, Jesús
  • Sánchez Morán, Irene
  • Zamarreño, Rubén
  • Prieto, Estefanía
  • Bolaños, Juan P.
  • Almeida, Angeles
Neurodegeneration in selective brain areas underlies the pathology of Alzheimer's disease (AD). Although oligomeric amyloid-β (Aβ) plays a central role in the AD pathogenesis, the mechanism of neuronal loss in response to Aβ remains elusive. The p53 tumor suppressor protein, a key regulator of cell apoptosis, has been described to accumulate in affected brain areas from AD patients. However, whether p53 plays any role in AD pathogenesis remains unknown. To address this issue, here we investigated the involvement of p53 on Aß-induced neuronal apoptosis. We found that exposure of neurons to oligomers of the amyloidogenic fragment 25–35 of the Aß peptide (Aβ25-35) promoted p53 protein phosphorylation and stabilization, leading to mitochondrial dysfunction and neuronal apoptosis. To address the underlying mechanism, we focused on cyclin dependent kinase-5 (Cdk5), a known p53-phosphorylating kinase. The results revealed that Aβ25-35 treatment activated Cdk5, and that inhibiting Cdk5 activity prevented p53 protein stabilization. Furthermore, Aβ25-35-mediated mitochondrial dysfunction and neuronal apoptosis were prevented by both genetic and pharmacological inhibition of either p53 or Cdk5 activities. This effect was mimicked with the full-length peptide Aβ1-42. To confirm the mechanism in vivo, Aβ25-35 was stereotaxically injected in the cerebral right ventricle of mice, a treatment that caused p53 protein accumulation, dendrite disruption and neuronal death. Furthermore, these effects were prevented in p53 knockout mice or by pharmacologically inhibiting p53. Thus, Aβ25-35 triggers Cdk5 activation to induce p53 phosphorylation and stabilization, which leads to neuronal damage. Inhibition of the Cdk5-p53 pathway may therefore represent a novel therapeutic strategy against Aβ-induced neurodegeneration., The authors are grateful to Bodegas R. López de Heredia Viña Tondonia for funding part of the work. This work was supported by The Instituto de Salud Carlos III (grant numbers PI15/00473; RD16/0019/0018); European Regional Development Fund; Ministerio de Economía y Competitividad (SAF2016-78114-R); European Union’s Horizon 2020 Research and Innovation Programme (grant agreement 686009); Junta de Castilla y León (grant number IES007P17); and Fundacion Ramon Areces. RL was funded by Ministerio de Educación, Cultura y Deporte (FPU fellowship AP2010-3655). ISM was funded by Junta Castilla y León (EDU/346/2013)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hippocampal neurons require a large pool of glutathione to sustain dendrite integrity and cognitive function

  • Fernandez-Fernandez, Seila
  • Bobo-Jimenez, Veronica
  • Requejo-Aguilar, Raquel
  • Gonzalez-Fernandez, Silvia
  • Resch-Beusher, Monica
  • Carabias-Carrasco, Mónica
  • Ros, Joaquim
  • Almeida, Angeles
  • Bolaños, Juan P.
Loss of brain glutathione has been associated with cognitive decline and neuronal death during aging and neurodegenerative diseases. However, whether decreased glutathione precedes or follows neuronal dysfunction has not been unambiguously elucidated. Previous attempts to address this issue were approached by fully eliminating glutathione, a strategy causing abrupt lethality or premature neuronal death that led to multiple interpretations. To overcome this drawback, here we aimed to moderately decrease glutathione content by genetically knocking down the rate-limiting enzyme of glutathione biosynthesis in mouse neurons in vivo. Biochemical and morphological analyses of the brain revealed a modest glutathione decrease and redox stress throughout the hippocampus, although neuronal dendrite disruption and glial activation was confined to the hippocampal CA1 layer. Furthermore, the behavioral characterization exhibited signs consistent with cognitive impairment. These results indicate that the hippocampal neurons require a large pool of glutathione to sustain dendrite integrity and cognitive function., This work was funded by the MINECO, Spain (SAF2016-78114-R to JPB; Red de Excelencia CONSOLREDOX SAF2015-71521-REDC to JPB and JR), H2020 European Commission, Belgium (BatCure Grant 666918 to JPB; PANA grant 686009 to AA), Instituto de Salud Carlos III, Spain (CIBERFES CB16/10/00282 to JPB; PI15/00473 and RD16/0019/0018 to AA), Junta de Castilla y León, Spain (IES007P17) and Fundación Ramón Areces, Spain (to AA). This work was funded by FEDER, European Commission, Belgium., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NF-κB Activity Initiates Human ESC-Derived Neural Progenitor Cell Differentiation by Inducing a Metabolic Maturation Program

  • Fitzpatrick, Lorna M.
  • Hawkins, Kate E.
  • Delhove, Juliette M. K. M.
  • Fernández, Emilio
  • Soldati, Chiara
  • Bullen, Louise F.
  • Nohturfft, Axel
  • Waddington, Simon N.
  • Medina, Diego L.
  • Bolaños, Juan P.
  • McKay, Tristan R.
Human neural development begins at embryonic day 19 and marks the beginning of organogenesis. Neural stem cells in the neural tube undergo profound functional, morphological, and metabolic changes during neural specification, coordinated by a combination of exogenous and endogenous cues. The temporal cell signaling activities that mediate this process, during development and in the postnatal brain, are incompletely understood. We have applied gene expression studies and transcription factor-activated reporter lentiviruses during in vitro neural specification of human pluripotent stem cells. We show that nuclear factor κB orchestrates a multi-faceted metabolic program necessary for the maturation of neural progenitor cells during neurogenesis., L.M.F. and K.E.H. were partly funded by St. George's, University of London. T.R.M., J.M.K.M.D., and S.N.W. were funded by ERC grant “Somabio” (260862) and the NC3Rs (NC/L001780/1). J.P.B. is funded by MINECO (SAF2016-78114-R) CIBERFES (CB16/10/00282), SP3-People-MC-ITN program (608381). L.M.F., T.R.M., C.S., D.L.M., and J.P.B. are all funded by Horizon 2020 grant BATCure (666918). S.N.W. received funding from UK Medical Research Council grants (G1000709 and MR/N026101/1, MR/R015325/1, MR/P026494/1, and MR/N019075/1) and from SPARKS (17UCL01)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Single-nucleotide polymorphism 309T>G in the MDM2 promoter determines functional outcome after stroke

  • Rodríguez González, Cristina
  • Ramos-Araque, María E.
  • Domínguez-Martínez, Marta
  • Sobrino, Tomás
  • Sánchez Morán, Irene
  • Agulla, Jesús
  • Delgado-Esteban, María
  • Gómez Sánchez, José Carlos
  • Bolaños, Juan P.
  • Castillo, José
  • Almeida, Angeles
[Background and Purpose] The E3 ubiquitin ligase MDM2 (murine double minute 2) is the main negative regulator of the p53 protein—a key player in neuronal apoptosis after ischemia. A functional single-nucleotide polymorphism in the human MDM2 gene promoter (rs2279744) regulates MDM2 protein expression. We investigated whether the MDM2 SNP309, by controlling p53-mediated apoptosis, determines functional outcome after stroke., [Methods] Primary cortical neurons were subjected to oxygen and glucose deprivation. Mice were subjected to ischemic (transient middle cerebral artery occlusion) or hemorrhagic (collagenase injection) stroke models. Protein and mRNA levels of MDM2 and p53 were measured in both neuronal and brain extracts. The interaction of MDM2 with p53 was disrupted by neuronal treatment with nutlin-3a. siRNA was used to knockdown MDM2 expression. We analyzed the link between the MDM2 SNP309 and functional outcome, measured by the modified Rankin Scale scores, in 2 independent hospital-based stroke cohorts: ischemic stroke cohort (408 patients) and intracerebral hemorrhage cohort (128 patients)., [Results] Experimental stroke and oxygen and glucose deprivation induced the expression of MDM2 in the brain and neurons, respectively. Moreover, oxygen and glucose deprivation promoted MDM2 binding with p53 in neurons. Disruption of the MDM2-p53 interaction with nutlin-3a, or MDM2 knockdown by siRNA, triggered p53 accumulation, which increased neuronal susceptibility to oxygen and glucose deprivation-induced apoptosis. Finally, we showed that patients harboring the G allele in the MDM2 promoter had higher MDM2 protein levels and showed better functional outcome after stroke than those harboring the T/T genotype. The T/T genotype was also associated with large infarct volume in ischemic stroke and increased lesion volume in patients with intracerebral hemorrhage., [Conclusions] Our results reveal a novel role for the MDM2-p53 interaction in neuronal apoptosis after ischemia and show that the MDM2 SNP309 determines the functional outcome of patients after stroke., This work was funded by Instituto de Salud Carlos III (PI15/00473, RD16/0019/0018, and RD16/0019/0001), European Regional Development Fund, Ministerio de Economía y Competitividad (SAF2016-78114-R), European Union’s Horizon 2020 Research and Innovation Programme (Grant Agreement 686009), and Junta de Castilla y León (IES007P17). Drs Rodríguez (RD16/0019/0018), Delgado-Esteban (CP0014/00010), and Sobrino (CPII17/00027) are supported by Instituto de Salud Carlos III., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Neuronal p38α mediates age‐associated neural stem cell exhaustion and cognitive decline

  • Moreno-Cugnon, Leire
  • Revuelta, Miren
  • Arrizabalaga, Olatz
  • Colié, Sandra
  • Moreno‐Valladares, Manuel
  • Jimenez-Blasco, Daniel
  • Gil-Bea, Francisco
  • Llarena, Irantzu
  • Bolaños, Juan P.
  • Nebreda, Ángel R.
  • Matheu, Ander
Neuronal activity regulates cognition and neural stem cell (NSC) function. The molecular pathways limiting neuronal activity during aging remain largely unknown. In this work, we show that p38MAPK activity increases in neurons with age. By using mice expressing p38α-lox and CamkII-Cre alleles (p38α∆-N), we demonstrate that genetic deletion of p38α in neurons suffices to reduce age-associated elevation of p38MAPK activity, neuronal loss and cognitive decline. Moreover, aged p38α∆-N mice present elevated numbers of NSCs in the hippocampus and the subventricular zone. These results reveal novel roles for neuronal p38MAPK in age-associated NSC exhaustion and cognitive decline., Instituto de Salud Carlos III, Grant/Award Number: CP16/00039, PI13/02277 and PI16/01580; FEDER Funds; Spanish Ministry of Economy and Competitiveness (MINECO), Grant/Award Number: CSD2010‐0045 and SAF2016‐78114‐R; CIBERFES, Grant/Award Number: CB16/10/00282
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Does APC/CCDH1 control the human brain size?: An Editorial Highlight for ‘A novel human Cdh1 mutation impairs anaphase-promoting complex/cyclosome (APC/C) activity resulting in microcephaly, psychomotor retardation, and epilepsy’ on page 103

  • Dohrn, Maike F.
  • Bolaños, Juan P.
This editorial highlights a study by Rodriguez, Sanchez-Moran et al. (2019) in the current issue of the Journal of Neurochemistry, in which the authors describe a microcephalic boy carrying the novel heterozygous de novo missense mutation c.560A> G; p.Asp187Gly in Cdh1/Fzr1 encoding the APC/C E3-ubiquitin ligase cofactor CDH1. A functional characterization of mutant APC/C confirms an aberrant division of neural progenitor cells, a condition known to determine the mouse brain cortex size. These data suggest that APC/C may contribute to the regulation of the human brain size. (Figure presented.)., JPB is funded by MINECO (SAF2016-78114-R), Instituto de Salud Carlos III (CIBERFES CB16/10/00282), Junta de Castilla y Leon (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigacion Biomedicina 2017 Fundacion BBVA, and Fundacion Ramon Areces.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells

  • Bueno, María J.
  • Jimenez-Renard, Verónica
  • Samino-Gené, Sara
  • Capellades, Jordi
  • Junza, Alexandra
  • López-Rodríguez, María L.
  • Garcia-Carceles, Javier
  • López-Fabuel, Irene
  • Bolaños, Juan P.
  • Chandel, Navdeep S.
  • Yanes, Óscar
  • Colomer, Ramón
  • Quintela-Fandino, Miguel
Upregulation of fatty acid synthase (FASN) is a common event in cancer, although its mechanistic and potential therapeutic roles are not completely understood. In this study, we establish a key role of FASN during transformation. FASN is required for eliciting the anaplerotic shift of the Krebs cycle observed in cancer cells. However, its main role is to consume acetyl-CoA, which unlocks isocitrate dehydrogenase (IDH)-dependent reductive carboxylation, producing the reductive power necessary to quench reactive oxygen species (ROS) originated during the switch from two-dimensional (2D) to three-dimensional (3D) growth (a necessary hallmark of cancer). Upregulation of FASN elicits the 2D-to-3D switch; however, FASN's synthetic product palmitate is dispensable for this process since cells satisfy their fatty acid requirements from the media. In vivo, genetic deletion or pharmacologic inhibition of FASN before oncogenic activation prevents tumor development and invasive growth. These results render FASN as a potential target for cancer prevention studies., M.Q.F. is a recipient of the following grants: FIS PI13/00430 and FIS PI16/00354 funded by the Instituto de Salud Carlos III (ISCIII) and co-funded by the European Regional Development Fund (ERDF) and AECC Scientific Foundation (Beca de Retorno 2010). R.C. is a recipient of the following grants: FIS PI11/00832 and FIS PI14/00726 funded by the Instituto de Salud Carlos III (ISCIII) and co-funded by the European Regional Development Fund (ERDF), II14/00009 and PIE15/00068 from the Ministerio de Sanidad, Spain. N.S.C. is a recipient of an NIH grant (5R35CA197532). O.Y.T. is a recipient of the grants BFU2014-57466 from the Ministerio de Economía y Competitividad (MINECO). J.P.B. is funded by MINECO (SAF2016-78114-R), Instituto de Salud Carlos III (RD12/0043/0021), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA, and Fundación Ramón Areces. This study was partially supported by the generous donations from Fundación CRIS Contra el Cáncer and AVON Spain. We thank Drs. Erwin Wagner and Nabil Djouder for their critical review of the paper.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Astrocytic mitochondrial ROS modulate brain metabolism and mouse behaviour

  • Vicente-Gutiérrez, Carlos
  • Bonora, Nicoló
  • Bobo-Jimenez, Veronica
  • Jimenez-Blasco, Daniel
  • López-Fabuel, Irene
  • Fernández, Emilio
  • Josephine, Charlene
  • Bonvento, Gilles
  • Enríquez, José Antonio
  • Almeida, Angeles
  • Bolaños, Juan P.
To satisfy its high energetic demand, the brain depends on the metabolic cooperation of various cell types. For example, astrocytic-derived lactate sustains memory consolidation by serving both as an oxidizable energetic substrate for neurons and as a signalling molecule. Astrocytes and neurons also differ in the regulation of glycolytic enzymes and in the organization of their mitochondrial respiratory chain. Unlike neurons, astrocytes rely on glycolysis for energy generation and, as a consequence, have a loosely assembled mitochondrial respiratory chain that is associated with a higher generation of mitochondrial reactive oxygen species (ROS). However, whether this abundant natural source of mitochondrial ROS in astrocytes fulfils a specific physiological role is unknown. Here we show that astrocytic mitochondrial ROS are physiological regulators of brain metabolism and neuronal function. We generated mice that inducibly overexpress mitochondrial-tagged catalase in astrocytes and show that this overexpression decreases mitochondrial ROS production in these cells during adulthood. Transcriptomic, metabolomic, biochemical, immunohistochemical and behavioural analysis of these mice revealed alterations in brain redox, carbohydrate, lipid and amino acid metabolic pathways associated with altered neuronal function and mouse behaviour. We found that astrocytic mitochondrial ROS regulate glucose utilization via the pentose-phosphate pathway and glutathione metabolism, which modulates the redox status and potentially the survival of neurons. Our data provide further molecular insight into the metabolic cooperation between astrocytes and neurons and demonstrate that mitochondrial ROS are important regulators of organismal physiology in vivo., This work was funded by MINECO (SAF2016-78114-R to J.P.B.), H2020 European Commission (BatCure grant 666918 to J.P.B.) and Fundación BBVA (to J.P.B.). A.A. is funded by H2020 European Commission (PANA grant 686009), Instituto de Salud Carlos III (PI15/00473 and RD16/0019/0018), Junta de Castilla y León (IES007P17) and Fundación Ramón Areces. J.A.E. is funded by MINECO (SAF2015-65633-R). The CNIC is supported by MINECO and Pro-CNIC Foundation, and is a SO-MINECO (award SEV-2015-0505). We thank the viral vector facility headed by A. Bemelmans for producing AAVs at MIRCen. This work was cofunded by FEDER. J.P.B. and J.A.E. are funded by CIBERFES (CB16/10/00282).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Targeting PFKFB3 alleviates cerebral ischemia-reperfusion injury in mice

  • Burmistrova, Olga
  • Olias-Arjona, Ana
  • Lapresa, Rebeca
  • Jimenez-Blasco, Daniel
  • Eremenko, Tatiana
  • Shishov, Dmitry
  • Romanov, Sergei
  • Zakurdaeva, Kristina
  • Almeida, Angeles
  • Fedichev, Peter O.
  • Bolaños, Juan P.
The glycolytic rate in neurons is low in order to allow glucose to be metabolized through the pentose-phosphate pathway (PPP), which regenerates NADPH to preserve the glutathione redox status and survival. This is controlled by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3), the pro-glycolytic enzyme that forms fructose-2,6-bisphosphate, a powerful allosteric activator of 6-phosphofructo-1-kinase. In neurons, PFKFB3 protein is physiologically inactive due to its proteasomal degradation. However, upon an excitotoxic stimuli, PFKFB3 becomes stabilized to activate glycolysis, thus hampering PPP mediated protection of redox status leading to neurodegeneration. Here, we show that selective inhibition of PFKFB3 activity by the small molecule AZ67 prevents the NADPH oxidation, redox stress and apoptotic cell death caused by the activation of glycolysis triggered upon excitotoxic and oxygen-glucose deprivation/reoxygenation models in mouse primary neurons. Furthermore, in vivo administration of AZ67 to mice significantly alleviated the motor discoordination and brain infarct injury in the middle carotid artery occlusion ischemia/reperfusion model. These results show that pharmacological inhibition of PFKFB3 is a suitable neuroprotective therapeutic strategy in excitotoxic-related disorders such as stroke., J.P.B. is funded by the MINECO (SAF2016-78114-R), CIBERFES (CB16/10/00282), H2020 European Commission (BatCure Grant 666918), Ayudas Fundación BBVA a Equipos de Investigación Científica en Biomedicina 2017 and Fundación Ramón Areces. A.A. is funded by H2020 European Commission (PANA grant 686009), Instituto de Salud Carlos III (PI15/00473; RD16/0019/0018) and Fundación Ramón Areces. J.P.B. and A.A. are in part funded by FEDER. This work was part of the “Escalera de Excelencia” program of the Junta de Castilla y León (CLU-2017-03) co-funded by the P.O. FEDER of Castilla y León 14–20.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Glucose metabolism links astroglial mitochondria to cannabinoid effects

  • Jimenez-Blasco, Daniel
  • Busquets-Garcia, Arnau
  • Hebert-Chatelain, Etienne
  • Serrat, Roman
  • Vicente-Gutiérrez, Carlos
  • Ioannidou, Christina
  • Gómez-Sotres, Paula
  • López-Fabuel, Irene
  • Resch-Beusher, Monica
  • Resel, Eva
  • Arnouil, Dorian
  • Saraswat, Dave
  • Varilh, Marjorie
  • Cannich, Astrid
  • Julio-Kalajzic, Francisca
  • Bonilla-Del Río, Itziar
  • Almeida, Angeles
  • Puente, Nagore
  • Achicallende, Svein
  • López-Rodríguez, María L.
  • Jollé, Charlotte
  • Déglon, Nicole
  • Pellerin, Luc
  • Josephine, Charlene
  • Bonvento, Gilles
  • Panatier, Aude
  • Lutz, Beat
  • Piazza, Pier Vincenzo
  • Guzmán, Manuel
  • Bellocchio, Luigi
  • Bouzier-Sore, Anne-Karine
  • Grandes, Pedro
  • Bolaños, Juan P.
  • Marsicano, Giovanni
Astrocytes take up glucose from the bloodstream to provide energy to the brain, thereby allowing neuronal activity and behavioural responses1,2,3,4,5. By contrast, astrocytes are under neuronal control through specific neurotransmitter receptors5,6,7. However, whether the activation of astroglial receptors can directly regulate cellular glucose metabolism to eventually modulate behavioural responses is unclear. Here we show that activation of mouse astroglial type-1 cannabinoid receptors associated with mitochondrial membranes (mtCB1) hampers the metabolism of glucose and the production of lactate in the brain, resulting in altered neuronal functions and, in turn, impaired behavioural responses in social interaction assays. Specifically, activation of astroglial mtCB1 receptors reduces the phosphorylation of the mitochondrial complex I subunit NDUFS4, which decreases the stability and activity of complex I. This leads to a reduction in the generation of reactive oxygen species by astrocytes and affects the glycolytic production of lactate through the hypoxia-inducible factor 1 pathway, eventually resulting in neuronal redox stress and impairment of behavioural responses in social interaction assays. Genetic and pharmacological correction of each of these effects abolishes the effect of cannabinoid treatment on the observed behaviour. These findings suggest that mtCB1 receptor signalling can directly regulate astroglial glucose metabolism to fine-tune neuronal activity and behaviour in mice., This work was funded by: INSERM, the European Research Council (Endofood, ERC–2010–StG–260515 and CannaPreg, ERC-2014-PoC-640923, MiCaBra, ERC-2017-AdG-786467), Fondation pour la Recherche Medicale (FRM, DRM20101220445), the Human Frontiers Science Program, Region Nouvelle Aquitaine and Agence Nationale de la Recherche (ANR; NeuroNutriSens ANR-13-BSV4-0006, CaCoVi ANR 18-CE16-0001-02, MitObesity ANR 18-CE14-0029-01, ORUPS ANR-16-CE37-0010-01 and BRAIN ANR-10-LABX-0043) (to G.M.); NIH/NIDA (1R21DA037678-01), Spanish Ministry of Science, Innovation and Universities (MCINU/FEDER; grants SAF2016-78114-R and RED2018-102576-T), Instituto de Salud Carlos III (CB16/10/00282), an EU BATCure grant (666918), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA and Fundación Ramón Areces (to J.P.B.); Instituto de Salud Carlos III (PI18/00285; RD16/0019/0018), the European Regional Development Fund, the European Union’s Horizon 2020 Research and Innovation Programme (grant agreement 686009), Junta de Castilla y León (IES007P17) and Fundación Ramón Areces to (A.A.); French State/ANR/IdEx (ANR-10-IDEX-03-02), Eu-Fp7 (FP7-PEOPLE-2013-IEF-623638) and Ramon y Cajal Investigator Program (RYC-2017-21776) (to A.B.-G.); FRM (SPF20121226369) (to R.S.); FRM (ARF20140129235) (to L.B.); Spanish Ministry of Science, Innovation and Universities (MCINU/FEDER; grants SAF2015-64945-R and RTI2018-095311-B-I00) (to M.G.); Canada Research Chair, Alzheimer Society of Canada—Brain Canada (17-09), Natural Sciences and Engineering Research Council (RGPIN-2015-05880), Canadian Breast Cancer Foundation (2015-317342), Canadian Health Research Institute (CIHR, 388808), New Brunswick Innovation Foundation, New Brunswick Health Research Foundation and Université de Moncton (to E.H.-C.); Basque Government (IT1230-19), Red de Trastornos Adictivos, Instituto de Salud Carlos III (ISC-III), European Regional Development Funds-European Union (ERDF-EU; RD16/0017/0012) and MINECO/FEDER, UE (SAF2015-65034-R) (to P.G.); University of the Basque Country PhD contract (PIF 16/251) (to S.A.); POP contract (BES-2016-076766, BES-C-2016-0051) (to I.B.-D.R.); French State/ANR (ANR-10-IDEX and TRAIL ANR-10-LABX-57); French-Swiss ANR-FNS (ANR-15- CE37-0012) (to A.-K.B.-S.); SFB/TRR 58 ‘Fear, anxiety, anxiety disorders’ (subproject A04); and CRC 1193 ‘Neurobiology of resilience’ (subproject B04) (to B.L.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fgr kinase is required for proinflammatory macrophage activation during diet-induced obesity

  • Acín-Pérez, Rebeca
  • Iborra, Salvador
  • Martí-Mateos, Yolanda
  • Cook, Emma C. L.
  • Conde-Garrosa, Ruth
  • Petcherski, Anton
  • Muñoz, María del Mar
  • Martínez de Mena, Raquel
  • Krishnan, Karthickeyan Chella
  • Jiménez, Concepción
  • Bolaños, Juan P.
  • Laakso, Markku
  • Lusis, Aldons J.
  • Shirihai, Orian S.
  • Sancho, David
  • Enríquez, José Antonio
Proinflammatory macrophages are key in the development of obesity. In addition, reactive oxygen species (ROS), which activate the Fgr tyrosine kinase, also contribute to obesity. Here we show that ablation of Fgr impairs proinflammatory macrophage polarization while preventing high-fat diet (HFD)-induced obesity in mice. Systemic ablation of Fgr increases lipolysis and liver fatty acid oxidation, thereby avoiding steatosis. Knockout of Fgr in bone marrow (BM)-derived cells is sufficient to protect against insulin resistance and liver steatosis following HFD feeding, while the transfer of Fgr-expressing BM-derived cells reverts protection from HFD feeding in Fgr-deficient hosts. Scavenging of mitochondrial peroxides is sufficient to prevent Fgr activation in BM-derived cells and HFD-induced obesity. Moreover, Fgr expression is higher in proinflammatory macrophages and correlates with obesity traits in both mice and humans. Thus, our findings reveal the mitochondrial ROS–Fgr kinase as a key regulatory axis in proinflammatory adipose tissue macrophage activation, diet-induced obesity, insulin resistance and liver steatosis., The METSIM study was supported by grants from the Academy of Finland (no. 321428), Sigrid Juselius Foundation, Finnish Foundation for Cardiovascular Research, Centre of Excellence of Cardiovascular and Metabolic Diseases and the Academy of Finland (to M.L.). Work in the laboratory of J.A.E. is funded by the CNIC and a grant by Ministerio de Ciencia, Innovación e Universidades (MICINN), Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional (FEDER; SAF2015-65633-R and RTI2018-099357-B-I00), the EU (UE0/MCA317433), the Biomedical Research Networking Center on Frailty and Healthy Ageing (CIBERFES-ISCiii) and the HFSP agency (RGP0016/2018). Work in the laboratory of D.S. is funded by the CNIC; the European Research Council (ERC-2016-Consolidator Grant 725091); the European Commission (635122-PROCROP H2020); MICINN, AEI and FEDER (SAF2016-79040-R and PID2019-108157RB); Comunidad de Madrid (B2017/BMD-3733 Immunothercan-CM); FIS-Instituto de Salud Carlos III, MICINN and FEDER (RD16/0015/0018-REEM); the Acteria Foundation; Atresmedia (Constantes y Vitales prize); and Fundació La Marató de TV3 (201723). Work in the laboratory of O.S.S. is funded by National Institutes of Health (NIH; R01 DK099618-05, R01 CA232056-01, R21AG060456-01 and R21 AG063373-01) and the American Diabetes Association (1-19-IBS-049). Work in laboratory of A.J.L. was supported by NIH-PO1HL028481 and NIH-R01DK117850 (A.J.L.). Work in the laboratory of M.L. was funded by the Academy of Finland. Work in the laboratory of J.P.B. was funded by Spanish Ministry of Science, Innovation and Universities (MCINU/FEDER; grants SAF2016-78114-R and RED2018‐102576‐T), Instituto de Salud Carlos III (CB16/10/00282), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA and Fundación Ramón Areces. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), MICINN and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505). K.C.K. is funded by NIH-K99 DK120875 and AHA Fellowship 18POST33990256. S.I. is funded by RYC-2016-19463 and RTI2018-094484-B-I00.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nuclear WRAP53 promotes neuronal survival and functional recovery after stroke

  • Sánchez Morán, Irene
  • Rodríguez González, Cristina
  • Lapresa, Rebeca
  • Agulla, Jesús
  • Sobrino, Tomás
  • Castillo, José
  • Bolaños, Juan P.
  • Almeida, Angeles
Failure of neurons to efficiently repair DNA double-strand breaks (DSBs) contributes to cerebral damage after stroke. However, the molecular machinery that regulates DNA repair in this neurological disorder is unknown. Here, we found that DSBs in oxygen/glucose-deprived (OGD) neurons spatiotemporally correlated with the up-regulation of WRAP53 (WD40-encoding p53-antisense RNA), which translocated to the nucleus to activate the DSB repair response. Mechanistically, OGD triggered a burst in reactive oxygen species that induced both DSBs and translocation of WRAP53 to the nucleus to promote DNA repair, a pathway that was confirmed in an in vivo mouse model of stroke. Noticeably, nuclear translocation of WRAP53 occurred faster in OGD neurons expressing the Wrap53 human nonsynonymous single-nucleotide polymorphism (SNP) rs2287499 (c.202C>G). Patients carrying this SNP showed less infarct volume and better functional outcome after stroke. These results indicate that WRAP53 fosters DNA repair and neuronal survival to promote functional recovery after stroke., This work was funded by the Instituto de Salud Carlos III (PI18/00265 and RD16/0019/0018 to A.A., RD16/0019/0001 to J.C., and CPII17/00027 to T.S.), European Regional Development Fund (FEDER) to Ministerio de Ciencia en Innovación (SAF2016-78114-R and RED2018-102576-T to J.P.B. and SAF2017-90794-REDT to A.A.), CIBERFES (CB16/10/00282 to J.P.B.), European Union’s Horizon 2020 Research and Innovation Programme (grant agreement 686009 to A.A.), Junta de Castilla y León (IES007P17 to A.A. and Escalera de Excelencia CLU-2017-03 Cofinanciado por el P.O. FEDER de Castilla y León to A.A. and J.P.B.), Fundación Ramón Areces (to A.A. and J.P.B.), and Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA (to J.P.B.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An ex vivo Approach to Assess Mitochondrial ROS by Flow Cytometry in AAV-tagged Astrocytes in Adult Mice

  • Bolaños, Juan P.
  • Vicente-Gutiérrez, Carlos
Mitochondrial reactive oxygen species (mROS) are naturally produced signalling molecules extremely relevant for understanding both health- and disease-associated biological processes. The study of mROS in the brain is currently underway to decipher their physiopathological roles and contributions in neurological diseases. Recent advances in this field have highlighted the importance of studying mROS signalling and redox biology at the cellular level. Neurons are especially sensitive to the harmful effects of excess mROS while astrocytic mROS have been shown to play a relevant physiological role in cerebral homeostasis and behaviour. However, given the complexity of the brain, investigating mROS formation in a specific cell-type in adult animals is methodologically challenging. Here we propose an approach to specifically assess mROS abundance in astrocytes that combines i) a targeting strategy based on the use of adeno-associated virus (AAV) vectors expressing the green fluorescent protein (GFP) under an astrocyte (glial fibrillary acidic protein or GFAP) promoter, along with, ii) a robust and widely extended protocol for the measurement of mROS by flow cytometry using commercial probes. The significance of this work is that it allows the selective study of astrocytic mROS abundance by means of easily accessible technology., This work was funded by MINECO (SAF2016-78114-R), Instituto de Salud Carlos III (CB16/10/00282), NIH/NIDA (1R21DA037678-01), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA, Fundación Ramón Areces and Junta de Castilla y León (Escalera de Excelencia CLU-2017-03). This protocol was originally described by Vicente-Gutierrez et al. (2019).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cell identity and nucleo-mitochondrial genetic context modulate OXPHOS performance and determine somatic heteroplasmy dynamics

  • Lechuga-Vieco, Ana V.
  • Latorre-Pellicer, Ana
  • Johnston, Iain G.
  • Prota, Gennaro
  • Gileadi, Uzi
  • Justo-Méndez, Raquel
  • Acín-Pérez, Rebeca
  • Martínez-De-Mena, Raquel
  • Fernández-Toro, José María
  • Jimenez-Blasco, Daniel
  • Mora, Alfonso
  • Nicolás-Ávila, José A.
  • Santiago, Demetrio J.
  • Priori, Silvia G.
  • Bolaños, Juan P.
  • Sabio, Guadalupe
  • Criado, Luis M.
  • Ruiz-Cabello, Jesús
  • Cerundolo, Vincenzo
  • Jones, Nick S.
  • Enríquez, José Antonio
Heteroplasmy, multiple variants of mitochondrial DNA (mtDNA) in the same cytoplasm, may be naturally generated by mutations but is counteracted by a genetic mtDNA bottleneck during oocyte development. Engineered heteroplasmic mice with nonpathological mtDNA variants reveal a nonrandom tissue-specific mtDNA segregation pattern, with few tissues that do not show segregation. The driving force for this dynamic complex pattern has remained unexplained for decades, challenging our understanding of this fundamental biological problem and hindering clinical planning for inherited diseases. Here, we demonstrate that the nonrandom mtDNA segregation is an intracellular process based on organelle selection. This cell type-specific decision arises jointly from the impact of mtDNA haplotypes on the oxidative phosphorylation (OXPHOS) system and the cell metabolic requirements and is strongly sensitive to the nuclear context and to environmental cues., This study was supported by MINECO SAF2015-65633-R to JAE, SAF2016-78114-R to J.P.B. and SAF2017- 84494-C2-1-R to J.R.-C. G.S. thanks MINECO-FEDER SAF2016-79126-R and Comunidad de Madrid IMMUNOTHERCAN-CM B2017/BMD-3733. N.S.J. thanks EP/N014529/1. CIBERFES (CB16/10/00282) to J.P.B. and J.A.E., and H2020 European Commission (BatCure grant 666918) to J.P.B. A.V.L.-V. was supported by SOFPI-fellowship from the MINECO. V.C. is supported by the UK Medical Research Council, Cancer Research UK (CRUK) (C399/A2291), and the Oxford Biomedical Research Centre. I.G.J. thanks the European Research Council (ERC- No. 805046-EvoConBiO). The CNIC is supported by MINECO and Pro-CNIC Foundation and is a SO-MINECO (award SEV-2015-0505). CIC biomaGUNE is supported by the Maria de Maeztu Units of Excellence Program from the Spanish State Research Agency (grant no. MDM-2017- 0720), ELKARTEK Program (grant no. KK-2019/bmG19), and BBVA Foundation (Ayudas a Equipos de investigación científica Biomedicina 2018)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

El complejo MDM2-P53 es esencial en la tolerancia isquémica neuronal inducida por el precondicionamiento

  • Vecino, Rebeca
Tesis doctoral presentada para lograr el título de Doctor por la Universidad de Salamanca, Un estímulo subtóxico en el cerebro (PC) promueve una situación de resistencia transitoria, que lo protege frente a un daño isquémico agudo posterior. Este estado de tolerancia isquémica se debe a la activación de mecanismos endógenos que promueven la supervivencia neuronal (Dirnagl et al., 2009, 2003; Gidday, 2006; Kirino, 2002; Wang et al., 2015). De hecho, se ha observado que aquellos pacientes que sufren, previo al ictus, uno o varios AITs presentan un mejor pronóstico funcional que aquellos pacientes sin AIT (Schaller, 2005; Wang et al., 2017; Wegener et al., 2004). Por ello, en la actualidad, se considera al AIT como el correlato clínico de una situación de PC. Así, el PC constituye una herramienta experimental eficaz en la identificación de las vías de neuroprotección asociadas a la tolerancia neuronal y frente a la isquemia. El empleo de dos modelos de PC distintos (NMDA-PC e IPC) ha permitido identificar, tanto in vitro como in vivo, las vías de señalización p53/PUMA/Caspasa-3 y Akt/MDM2/p53 con un papel clave en el balance entre la supervivencia y la muerte neuronal tras la isquemia. Así, el PC induce la fosforilación temprana de Akt, cuya activación promueve la fosforilación de MDM2 y posterior translocación al núcleo celular. De este modo, se fomenta la formación del complejo MDM2-p53, clave para la desestabilización de la proteína p53. Todo esto previene la activación de la vía proapoptótica p53/PUMA/Caspasa-3 y favorece la supervivencia neuronal tras la isquemia (Vecino et al., 2018). Resultados previos de nuestro grupo han identificado que el polimorfismo humano o SNP Arg72Pro de Tp53 modula la susceptibilidad de las neuronas a la isquemia y condiciona el pronóstico funcional de pacientes de ictus isquémico y hemorrágico (Gomez-Sanchez et al., 2011). Además, este SNP determina la neovascularización y recuperación neurológica tras el ictus hemorrágico (Rodríguez et al., 2017). En este sentido, hemos identificado la función moduladora del polimorfismo Arg72Pro de Tp53 en la supervivencia neuronal asociada al PC y su relevancia clínica en el pronóstico funcional de pacientes que experimentan un AIT previo al ictus (Ramos-Araque et al., 2019)., Este trabajo ha sido financiado con subvenciones concedidas por el Ministerio de Ciencia, Innovación y Universidades, a través de una ayuda para la formación de profesorado universitario (FPU; BOE A-2015-12849); así como una ayuda para financiar la contratación predoctoral de personal investigador de la Junta de Castilla y León (ORDEN EDU/128/2015). Asimismo, este trabajo se ha financiado mediante los proyectos del Ministerio de Economía, Industria y Competitividad (SAF 2013-41177-R, SAF 2016-78114-R); el Instituto de Salud Carlos III (CP0014/00010, PI12/00685, PI15/00473, RD16/0019/0018); la Junta de Castilla y León (BIO/SA35/15) y los fondos FEDER (European regional development funding).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Cell identity and nucleo-mitochondrial genetic context modulate OXPHOS performance and determine somatic heteroplasmy dynamics

  • Lechuga-Vieco, A.V.
  • Latorre-Pellicer, A.
  • Johnston, I.G.
  • Prota, G.
  • Gileadi, U.
  • Justo-Méndez, R.
  • Acín-Pérez, R.
  • Martínez-de-Mena, R.
  • Fernández-Toro, J.M.
  • Jimenez-Blasco, D.
  • Mora, A.
  • Nicolás-Ávila, J.A.
  • Santiago, D.J.
  • Priori, S.G.
  • Bolaños, J.P.
  • Sabio, G.
  • Criado, L.M.
  • Ruíz-Cabello, J.
  • Cerundolo, V.
  • Jones, N.S.
  • Enríquez, J.A.
Heteroplasmy, multiple variants of mitochondrial DNA (mtDNA) in the same cytoplasm, may be naturally generated by mutations but is counteracted by a genetic mtDNA bottleneck during oocyte development. Engineered heteroplasmic mice with nonpathological mtDNA variants reveal a nonrandom tissue-specific mtDNA segregation pattern, with few tissues that do not show segregation. The driving force for this dynamic complex pattern has remained unexplained for decades, challenging our understanding of this fundamental biological problem and hindering clinical planning for inherited diseases. Here, we demonstrate that the nonrandom mtDNA segregation is an intracellular process based on organelle selection. This cell type-specific decision arises jointly from the impact of mtDNA haplotypes on the oxidative phosphorylation (OXPHOS) system and the cell metabolic requirements and is strongly sensitive to the nuclear context and to environmental cues.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Hippocampal neurons require a large pool of glutathione to sustain dendrite integrity and cognitive function

  • Fernandez-Fernandez, Seila
  • Bobo-Jimenez, Veronica
  • Requejo-Aguilar, Raquel
  • Gonzalez-Fernandez, Silvia
  • Resch, Monica
  • Carabias-Carrascoa, Monica
  • Ros Salvador, Joaquim
  • Almeida, Angeles
  • Bolaños, Juan P.
Loss of brain glutathione has been associated with cognitive decline and neuronal death during aging and neurodegenerative diseases. However, whether decreased glutathione precedes or follows neuronal dysfunction has not been unambiguously elucidated. Previous attempts to address this issue were approached by fully eliminating glutathione, a strategy causing abrupt lethality or premature neuronal death that led to multiple interpretations. To overcome this drawback, here we aimed to moderately decrease glutathione content by genetically knocking down the rate-limiting enzyme of glutathione biosynthesis in mouse neurons in vivo. Biochemical and morphological analyses of the brain revealed a modest glutathione decrease and redox stress throughout the hippocampus, although neuronal dendrite disruption and glial activation was confined to the hippocampal CA1 layer. Furthermore, the behavioral characterization exhibited signs consistent with cognitive impairment. These results indicate that the hippocampal neurons require a large pool of glutathione to sustain dendrite integrity and cognitive function., This work was funded by the MINECO, Spain (SAF2016-78114-R to JPB; Red de Excelencia CONSOLREDOX SAF2015-71521-REDC to JPB and JR), H2020 European Commission, Belgium (BatCure Grant 666918 to JPB; PANA grant 686009 to AA), Instituto de Salud Carlos III, Spain (CIBERFES CB16/10/00282 to JPB; PI15/00473 and RD16/ 0019/0018 to AA), Junta de Castilla y León, Spain (IES007P17) and Fundación Ramón Areces, Spain (to AA). This work was funded by FEDER, European Commission, Belgium.